Article | August 12, 2020

How To Control And Modify The Release Of Today's Insoluble, Potent APIs

By Tom Chang

capsule

Synchronizing and controlling API delivery, extrusion-spheronization is a robust technique offers pharmaceutical companies a reliable, efficient way to manufacture today’s most effective patient-centric therapeutics.

Manufacturing spherical oral solid dose beads via extrusion-spheronization is a well-understood technology perfect for controlling and modifying the release of today’s insoluble, potent APIs. Suitable for a broad range of oral solid dose (OSD) therapeutics, extrusion-spheronization offers an efficient route to more effective, patient-centric therapeutics and a reliable way to manufacture complex OSD drug products.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: